AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 71 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.2%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Syncona Portfolio Ltd | 21,346,829 | $49,738,112 | 74.10% |
TFG Asset Management GP Ltd | 12,000,000 | $27,960,000 | 5.10% |
Paradigm Biocapital Advisors LP | 14,406,782 | $33,567,802 | 2.28% |
Lynx1 Capital Management LP | 1,363,025 | $3,175,848 | 2.10% |
Deep Track Capital, LP | 15,000,000 | $34,950,000 | 1.35% |
Affinity Asset Advisors, LLC | 1,992,466 | $4,642,446 | 1.31% |
DAFNA Capital Management LLC | 928,253 | $2,162,829 | 0.67% |
Frazier Life Sciences Management, L.P. | 3,746,857 | $8,730,177 | 0.58% |
ARMISTICE CAPITAL, LLC | 6,900,000 | $16,077,000 | 0.25% |
Blackstone Inc. | 20,485,611 | $47,731,474 | 0.20% |
HARBOR CAPITAL ADVISORS, INC. | 286,065 | $666,531 | 0.14% |
Alphabet Inc. | 698,262 | $1,626,950 | 0.10% |
Ikarian Capital, LLC | 262,694 | $612,078 | 0.07% |
INNOVIS ASSET MANAGEMENT LLC | 63,179 | $147,208 | 0.06% |
WEALTH EFFECTS LLC | 47,000 | $109,510 | 0.05% |
Cormorant Asset Management, LP | 392,167 | $913,749 | 0.05% |
Perpetual Ltd | 1,973,048 | $4,597,202 | 0.05% |
LGT CAPITAL PARTNERS LTD. | 550,000 | $1,281,500 | 0.05% |
EWA, LLC | 18,317 | $67,040 | 0.04% |
UBS OCONNOR LLC | 585,919 | $1,365,191 | 0.03% |
External links
This page lists AUTOLUS THERAPEUTICS PLC's shareholders in Q3 2023. To view AUTOLUS THERAPEUTICS PLC's shareholder history, click here.